Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jun;37(6):1093-1094.
doi: 10.1111/jdv.19080.

Aryl-hydrocarbon receptor agonist: A novel topical therapeutic approach for inflammatory skin diseases

Valeria Aoki  1 , Raquel Leão Orfali  1
Affiliations
Comment

Aryl-hydrocarbon receptor agonist: A novel topical therapeutic approach for inflammatory skin diseases

Valeria Aoki et al. J Eur Acad Dermatol Venereol. 2023 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Boehncke WH. Etiology and pathogenesis of psoriasis. Rheum Dis Clin North Am. 2015;41:665-75. https://doi.org/10.1016/j.rdc.2015.07.013
    1. Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018;4:1. https://doi.org/10.1038/s41572-018-0001-z
    1. Furue M, Hashimoto-Hachiya A, Tsuji G. Aryl hydrocarbon receptor in atopic dermatitis and psoriasis. Int J Mol Sci. 2019;20:5424. https://doi.org/10.3390/ijms20215424
    1. Bissonnette R, Saint-Cyr Proulx E, Jack C, Maari C. Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research. J Eur Acad Dermatol Venereol. 2023; 37:1168-74. https://doi.org/10.1111/jdv.18925
    1. Strober B, Stein Gold L, Bissonnette R, Armstrong AW, Kircik L, Tyring SK, et al. One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: results from the PSOARING 3 trial. J Am Acad Dermatol. 2022;87:800-6. https://doi.org/10.1016/j.jaad.2022.06.1171

LinkOut - more resources